Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Purchase | 2024-12-18 4:11 pm | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 1,250,000 | $6 | $7,500,000 | 2,984,752 (Indirect Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:48 pm | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 20,392 | $4.5556 | $92,898 | 125,657 (Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:48 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 48,847 | $4.5556 | $222,527 | 294,788 (Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:47 pm | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 13,935 | $4.5556 | $63,482 | 100,547 (Direct) | View |
| 2024-11-29 Sale | 2024-12-03 5:46 pm | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 22,081 | $4.5556 | $100,592 | 137,880 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:31 am | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 14,851 | $6.4726 | $96,125 | 146,049 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:29 am | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 22,528 | $6.4726 | $145,815 | 330,735 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:28 am | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 9,884 | $6.4726 | $63,975 | 62,520 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:26 am | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 10,875 | $6.4726 | $70,390 | 114,482 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 08:24 am | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 14,051 | $6.4726 | $90,947 | 159,961 (Direct) | View |
| 2024-07-11 Sale | 2024-07-15 08:36 am | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 13,330 | $5.9734 | $79,625 | 160,900 (Direct) | View |
| 2024-07-11 Sale | 2024-07-15 08:35 am | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 20,293 | $5.9734 | $121,218 | 353,263 (Direct) | View |
| 2024-07-11 Sale | 2024-07-15 08:34 am | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 8,897 | $5.9734 | $53,145 | 72,404 (Direct) | View |
| 2024-07-11 Sale | 2024-07-15 08:32 am | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 9,769 | $5.9734 | $58,354 | 125,357 (Direct) | View |
| 2024-07-11 Sale | 2024-07-15 08:30 am | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 12,645 | $5.9734 | $75,534 | 174,012 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-12 Disposition | 2024-12-13 6:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 200,000 | $10.04 | 5,084,332 (Direct) | View |
| 2024-12-11 Disposition | 2024-12-13 6:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 200,000 | $8.53 | 5,084,332 (Direct) | View |
| 2024-12-04 Disposition | 2024-12-06 6:44 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 20,000 | $4.46 | 5,884,332 (Direct) | View |
| 2024-12-05 Disposition | 2024-12-06 6:44 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 20,000 | $4.79 | 5,884,332 (Direct) | View |
| 2024-12-06 Disposition | 2024-12-06 6:44 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 20,000 | $5.23 | 5,884,332 (Direct) | View |
| 2024-11-25 Disposition | 2024-11-27 6:24 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 20,000 | $4.97 | 5,944,332 (Direct) | View |
| 2024-11-21 Exercise | 2024-11-21 3:07 pm | N/A 2030-10-10 | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 12,900 | $0 | 2,107,603 (Direct) | View |
| 2024-11-21 Exercise | 2024-11-21 3:07 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 12,900 | $1.55 | 2,107,603 (Direct) | View |
| 2024-11-06 Disposition | 2024-11-08 8:58 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 7,500 | $5.33 | 5,964,332 (Direct) | View |
| 2024-11-08 Disposition | 2024-11-08 8:58 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 7,500 | $4.92 | 5,964,332 (Direct) | View |
| 2024-11-07 Disposition | 2024-11-08 8:58 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 7,500 | $5.19 | 5,964,332 (Direct) | View |
| 2024-11-01 Disposition | 2024-11-01 6:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 7,500 | $5.27 | 6,009,332 (Direct) | View |
| 2024-10-30 Disposition | 2024-11-01 6:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 6,000 | $5.38 | 6,009,332 (Direct) | View |
| 2024-10-31 Disposition | 2024-11-01 6:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 7,500 | $5.3 | 6,009,332 (Direct) | View |
| 2024-10-28 Disposition | 2024-10-28 6:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 11,711 | $5.58 | 6,022,852 (Direct) | View |
| 2024-10-24 Disposition | 2024-10-28 6:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 16,427 | $5.53 | 6,022,852 (Direct) | View |
| 2024-10-25 Disposition | 2024-10-28 6:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 1,597 | $5.8 | 6,022,852 (Direct) | View |
| 2024-10-24 Disposition | 2024-10-28 6:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Aguilar Laura K. 10% Owner | 1,194 | $5.72 | 6,022,852 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:41 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | PAPA JOSEPH C Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:40 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Nguyen Diem Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:39 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Nabel Gary J. Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:39 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:37 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:36 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Loggia Nicoletta Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:35 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Gaeta Renee Director | 14,240 | $0 | 14,240 (Direct) | View |
| 2024-06-26 Option Award | 2024-06-27 08:34 am | N/A 2034-06-26 | Candel Therapeutics Inc. | CADL | Benz Edward J. JR Director | 14,240 | $0 | 14,240 (Direct) | View |
Ownership | 2024-01-19 08:30 am | N/A N/A | Candel Therapeutics Inc. | CADL | Schoch Charles See Remarks | 0 | $0 | 145,799 (Direct) | View |
| 2023-11-28 Tax Withholding | 2023-11-30 5:00 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 17,328 | $0.9 | 174,230 (Direct) | View |
| 2023-11-28 Tax Withholding | 2023-11-30 5:00 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 43,443 | $0.9 | 373,556 (Direct) | View |
| 2023-11-28 Tax Withholding | 2023-11-30 5:00 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Nichols William Garrett Chief Medical Officer | 12,175 | $0.9 | 135,126 (Direct) | View |
| 2023-11-28 Tax Withholding | 2023-11-30 5:00 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Barone Francesca Chief Scientific Officer | 19,748 | $0.9 | 186,657 (Direct) | View |
| 2023-11-28 Tax Withholding | 2023-11-30 5:00 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Amello Jason Chief Financial Officer | 20,153 | $0.9 | 202,009 (Direct) | View |
| 2023-11-26 Option Award | 2023-11-28 4:30 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tak Paul Peter Chief Executive Officer | 180,108 | $0 | 416,999 (Direct) | View |
| 2023-11-26 Option Award | 2023-11-28 4:30 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Tyagarajan Seshu Chief Technology Officer | 104,516 | $0 | 191,558 (Direct) | View |